Country |
|
Opiates |
Cocaine |
Amphetamines |
Ecstasy |
Hallucinogens |
Cannabis |
Others |
|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
32.0 |
7.0 |
10.0 |
3.0 |
1.0 |
37.0 |
10.0 |
Czech Republic |
|
25.9 |
0.2 |
50.0 |
0.6 |
0.4 |
18.0 |
4.9 |
Denmark |
|
50.9 |
4.5 |
4.8 |
1.1 |
0.0 |
26.6 |
12.1 |
Germany |
(2) |
54.0 |
7.0 |
6.0 |
|
0.0 |
28.0 |
5.0 |
Greece |
|
89.1 |
1.4 |
0.0 |
0.4 |
0.1 |
7.5 |
1.5 |
Spain |
(3) |
58.0 |
27.0 |
1.0 |
1.0 |
0.0 |
11.0 |
2.0 |
France |
(4) |
70.1 |
6.1 |
0.2 |
1.1 |
0.3 |
18.8 |
3.4 |
Ireland |
(5) |
61.4 |
1.8 |
0.4 |
6.2 |
0.2 |
27.2 |
2.8 |
Italy |
(6) |
|
|
|
|
|
|
100.0 |
Cyprus |
|
67.6 |
8.6 |
0.4 |
2.6 |
0.0 |
19.0 |
1.8 |
Latvia |
|
80.0 |
0.0 |
2.0 |
0.0 |
0.0 |
2.0 |
16.0 |
Lithuania |
(6) |
64.1 |
0.1 |
1.6 |
|
0.2 |
0.5 |
33.5 |
Luxembourg |
(7) |
76.6 |
11.3 |
0.0 |
0.0 |
0.0 |
8.0 |
4.1 |
Hungary |
(8) |
20.7 |
1.1 |
8.4 |
|
0.7 |
35.4 |
33.7 |
Malta |
|
78 |
8.0 |
0.0 |
0.7 |
0.0 |
13.3 |
0.0 |
Netherlands |
|
35.0 |
39.0 |
3.0 |
1.0 |
0.0 |
20.0 |
2.0 |
Austria |
(9) |
100.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Poland |
(10) |
31.6 |
0.5 |
8.3 |
0.0 |
0.6 |
|
59.0 |
Portugal |
(11) |
81.4 |
4.6 |
0.1 |
0.5 |
0.3 |
10.7 |
2.4 |
Slovenia |
(12) |
89.6 |
0.9 |
0.3 |
0.2 |
0.0 |
9.0 |
0.0 |
Slovakia |
|
50.9 |
0.8 |
17.8 |
0.6 |
0.4 |
15.6 |
13.9 |
Finland |
|
37.7 |
0.2 |
30.4 |
0.4 |
0.3 |
22.9 |
8.1 |
Sweden |
|
31.9 |
1.2 |
35.2 |
0.9 |
0.1 |
22.0 |
8.7 |
United Kingdom |
(13) |
72.0 |
9.0 |
3.0 |
1.0 |
0.1 |
11.0 |
3.9 |
Bulgaria |
|
95.3 |
0.7 |
0.4 |
0.0 |
0.0 |
2.1 |
1.5 |
Romania |
|
83.0 |
1.0 |
0.0 |
0.0 |
0.0 |
3.0 |
13.0 |
Notes: Data were not available for: Estonia, Norway, Turkey. (1) Last data available refer to 1999. (2) Data on amphetamines include amphetamines and ecstasy. (2) Last data available refer to 2002. (3) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. (4) Last data available refer to 2002. (5) Data on clients by gender and substance of abuse are not available. (6) Data on amphetamines include amphetamines and ecstasy. (7) Last data available refer to 2002. (8) Data on amphetamines include amphetamines and ecstasy. (9) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. (10) Data on amphetamines include amphetamines and ecstasy. (11) Data by gender refer to first treatments. (12) Data refer only to outpatient treatment centres. (13) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2000 and 31 March 2001 combined. Sources: 2004 Reitox national reports - standard table 3 See [Table TDI-1] for details on sources. | ||||||||